Mobile health application to support CPAP therapy in obstructive sleep apnoea: design, feasibility and perspectives.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
30
08
2019
accepted:
04
12
2019
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
15
2
2020
Statut:
epublish
Résumé
Current continuous positive airway pressure (CPAP) devices can be monitored remotely; however, in-person visits are kept for clinical follow-up in order to promote CPAP use and resolve potential side-effects. Mobile health is a promising way to provide remote and easy clinical control for CPAP follow-up and support. We aimed to evaluate the feasibility and acceptance by obstructive sleep apnoea (OSA) patients and healthcare professionals of a newly designed mobile app (Appnea-Q) to promote clinical control through a self-monitoring tool for patients with CPAP supervised by sleep professionals. Appnea-Q incorporates a simple follow-up questionnaire with automated responses, together with frequent problems and lifestyle recommendations sections. Feasibility, acceptance and usefulness were assessed. First, an internal validation was performed during outpatient CPAP follow-up visits with sleep professionals from various sleep units. Second, an external validation was performed in a subgroup of 15 patients at home. Most patients (n=75) considered the app useful and were willing to use it and recommend it (72-88%). Up to 64.87% agreed on its capacity to reduce hospital visits. Appnea-Q was rated as acceptable (79.37±19.29) by the system usability score. Sleep professionals (n=30) concurred on its usefulness for OSA patient follow-up, particularly during the first month of CPAP therapy. The external validation showed its feasibility among 11 out of 15 patients and their data were received accordingly on the professionals' web platform. According to our validation process, and the viewpoints of the patients and professionals, our new mobile app is a feasible and well-received tool for personal OSA management. Future clinical trials should substantiate its performance and cost-effectiveness in the clinical arena.
Sections du résumé
BACKGROUND
BACKGROUND
Current continuous positive airway pressure (CPAP) devices can be monitored remotely; however, in-person visits are kept for clinical follow-up in order to promote CPAP use and resolve potential side-effects. Mobile health is a promising way to provide remote and easy clinical control for CPAP follow-up and support. We aimed to evaluate the feasibility and acceptance by obstructive sleep apnoea (OSA) patients and healthcare professionals of a newly designed mobile app (Appnea-Q) to promote clinical control through a self-monitoring tool for patients with CPAP supervised by sleep professionals.
METHODS
METHODS
Appnea-Q incorporates a simple follow-up questionnaire with automated responses, together with frequent problems and lifestyle recommendations sections. Feasibility, acceptance and usefulness were assessed. First, an internal validation was performed during outpatient CPAP follow-up visits with sleep professionals from various sleep units. Second, an external validation was performed in a subgroup of 15 patients at home.
RESULTS
RESULTS
Most patients (n=75) considered the app useful and were willing to use it and recommend it (72-88%). Up to 64.87% agreed on its capacity to reduce hospital visits. Appnea-Q was rated as acceptable (79.37±19.29) by the system usability score. Sleep professionals (n=30) concurred on its usefulness for OSA patient follow-up, particularly during the first month of CPAP therapy. The external validation showed its feasibility among 11 out of 15 patients and their data were received accordingly on the professionals' web platform.
CONCLUSIONS
CONCLUSIONS
According to our validation process, and the viewpoints of the patients and professionals, our new mobile app is a feasible and well-received tool for personal OSA management. Future clinical trials should substantiate its performance and cost-effectiveness in the clinical arena.
Identifiants
pubmed: 32055630
doi: 10.1183/23120541.00220-2019
pii: 00220-2019
pmc: PMC7008136
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: M. Suarez-Giron has nothing to disclose. Conflict of interest: O. Garmendia has nothing to disclose. Conflict of interest: V. Lugo has nothing to disclose. Conflict of interest: C. Ruiz has nothing to disclose. Conflict of interest: N. Salord has nothing to disclose. Conflict of interest: X. Alsina has nothing to disclose. Conflict of interest: R. Farre reports contracts between the University of Barcelona, ResMed and ANTADIR to evaluate CPAP devices at the bench. Conflict of interest: J.M. Montserrat reports an official government grant from the Ministry of Economy Industry and Competitiveness, and that Philips Respironics supported one of the researchers. Conflict of interest: M. Torres has nothing to disclose.
Références
Sleep Med Rev. 2003 Feb;7(1):81-99
pubmed: 12586532
Arch Bronconeumol. 2015 Dec;51(12):611-2
pubmed: 26497416
Sleep Med Clin. 2016 Dec;11(4):445-459
pubmed: 28118869
J Comorb. 2017 Aug 24;7(1):96-111
pubmed: 29359124
Arch Bronconeumol. 2018 Sep;54(9):491-492
pubmed: 29530350
Telemed J E Health. 2018 May;24(5):351-359
pubmed: 29027869
BMJ Open. 2017 Aug 3;7(8):e016242
pubmed: 28775188
Chest. 2016 Jun;149(6):1556-65
pubmed: 26970035
Arch Intern Med. 2012 May 28;172(10):773-9
pubmed: 22507696
BMC Med Inform Decis Mak. 2016 Sep 15;16(1):120
pubmed: 27630020
BMC Health Serv Res. 2017 Nov 28;17(1):784
pubmed: 29183372
Eur Respir J. 2017 Feb 8;49(2):
pubmed: 28179438
J Med Internet Res. 2018 Jan 26;20(1):e31
pubmed: 29374004
Interact J Med Res. 2014 Feb 19;3(1):e6
pubmed: 24554392
ERJ Open Res. 2018 Apr 16;4(2):
pubmed: 29670891
N Engl J Med. 2014 Jul 24;371(4):372-9
pubmed: 25054722
Sleep. 2016 Mar 01;39(3):501-9
pubmed: 26446115
Telemed J E Health. 2013 Oct;19(10):786-90
pubmed: 23931702
WMJ. 2009 Aug;108(5):246-9
pubmed: 19743755
Sleep Med. 2017 Nov;39:77-83
pubmed: 29157591
Am J Respir Crit Care Med. 2018 Jan 1;197(1):12-14
pubmed: 28926279
J Gen Intern Med. 2015 Aug;30(8):1063-70
pubmed: 25691239
Cochrane Database Syst Rev. 2014 Jan 08;(1):CD007736
pubmed: 24399660
Sleep Med Clin. 2016 Jun;11(2):161-71
pubmed: 27236054
Am J Respir Crit Care Med. 2018 Jan 1;197(1):117-126
pubmed: 28858567
N Engl J Med. 2016 Jul 14;375(2):154-61
pubmed: 27410924
J Clin Sleep Med. 2017 Nov 15;13(11):1349-1354
pubmed: 28992831
BMJ Open. 2018 Feb 15;8(2):e018688
pubmed: 29449293
Int J Med Inform. 2016 Sep;93:57-69
pubmed: 27435948
Nat Sci Sleep. 2018 Jan 23;10:21-34
pubmed: 29416383
JAMA. 2013 Dec 11;310(22):2407-15
pubmed: 24327037
J Telemed Telecare. 2017 Jan;23(1):14-18
pubmed: 26672606
Thorax. 2015 Nov;70(11):1054-61
pubmed: 26310452